By Pete Bianco
The seven companies awarded vaccine contracts through “Operation Warp Speed” use new technologies never used before in vaccines for humans. Technologies that some say, will genetically alter those who receive it.
As strange as this sounds that is just the beginning of a strange story.
A great deal of secrecy surrounds the details of these new vaccines. The contracts for “Operation Warp Speed” were awarded to vaccine makers through a military defense contractor. This unusual move was initiated by the Trump administration.
Funneling funding through a defense contractor prevents the public from being informed about risks associated with the vaccines. This move may disqualify public records requests, and make additional documents exempt from public disclosure for five years, according to NPR.
Advanced Technology International (ATI) is the military defense contractor who is the middle-man on close to $10 billion. This money was allocated by the US congress.
What types of work is ATI already engaged with? ATI manages a company that uses gene-editing, nanotechnology, “telehealth solutions,” artificial limbs and brain implants. They are also currently developing a wearable device that would diagnose individuals with coronavirus before symptoms appear.
Big Pharma career executive Moncef Slaoui, who heads Operation Warp Speed, said those who receive Warp Speed’s vaccines will be monitored using “incredibly precise … tracking systems” that will “ensure that patients each get two doses of the same vaccine and to monitor them for adverse health effects.”
Slaoui also noted that tech giants Google and Oracle have been contracted as part of this “tracking system” but did not specify their exact roles beyond helping to “collect and track vaccine data.”
Oracle’s CEO has called for a national identification card as far back as 2001, to be issued to all U.S. at that time it was under the guise of terrorist attacks. At that time CEO Ellison had reportedly offered to give the necessary software to the U.S. government for free.
Another new technology uses a thumbnail-sized patch studded with microneedles to deliver the vaccine instead of a syringe. The new delivery may be more comforting but the DNA/RNA technology still must be scrutinized.
One of the five finalists of Warp Speed is the company called Moderna, originally written as ModeRNA. They have never made a vaccine before. Tal Zaks, the CMO of Moderna, frankly discloses that mRNA vaccines are intended to rewrite your genetic code and “hack the software of life”.
Moderna is working on a new class of medicines that uses messenger RNA. In this work, Moderna is partnering with Amazon to utilize their on-demand cloud computing.
COVID-19 mRNA vaccines are designed to instruct your cells to make the SARS-CoV-2 spike protein. It does this through a process called transfection. Transfection is also used to create genetically engineered organisms. According to Dr. Carrie Madej,
“If you look at the definition of transfection, it will tell you that it can be a temporary change in the cell. And I think that is what the vaccine manufacturers are banking on.
Or, it’s a possibility for it to become stable, to be taken up into the genome, and to be so stable that it will start replicating when the genome replicates. Meaning it is now a permanent part of your genome. That’s a chance that we’re taking. It could be temporary, or it could be permanent.”
Another company, Inovio, is developing a coronavirus vaccine that uses a double-stranded ring of DNA known as a plasmid. Using a hand-held device that creates an electric current near the injection site, pores within the cell open, allowing the plasmid to enter.
The other new DNA-based vaccine technology for this coronavirus uses adenovirus. At least three companies, CanSino Biologics, AstraZeneca and Johnson & Johnson, are using adenovirus for their vaccines. The team at Oxford is using a chimpanzee adenovirus as a vector.
According to Organic Consumers Association the inconvenient truth about DNA vaccines is that they will permanently alter your DNA.
Adenovirus has been used for years as a tool for gene therapy, but companies are now applying it to vaccines.
According to a 2015 New York Times article about DNA vaccines, “The viruses invade human cells with their DNA payloads, and the synthetic gene is incorporated into the recipient’s own DNA.”
Hildegund C.J. Ertl, a professor at the Wistar Institute’s Vaccine & Immunotherapy Center has a different perspective on the adenovirus vaccine. He states “It goes into the nucleus, but it does not insert into the genome, it’s a fairly transient effect.”
Pharmaceutical companies also convinced doctors across the US and around the world that concerns regarding opiate addiction and abuse amounted to a “medical myth”.
Reuters states that the claim that a COVID-19 vaccine will genetically modify humans is false.
All Operation Warp Speed vaccine manufacturers will be exempt from liability for any damages their vaccines cause. Additionally, those who administer these vaccines will not be liable for damages.
The six different vaccines that are part of Operation Warp Speed will be produced by the following companies, AstraZeneca, Moderna, Pfizer, Novavax, Johnson & Johnson, and Sanofi partnered with GlaxoSmithKline.
The HHS secretary, Alex Azar said on FOX Business news there may be different vaccines for different demographic groups.
In 1976, there was a push to vaccinate all Americans for swine flu. Forty-six million Americans obediently took the shot and 4,000 claimed damages. Here is the archived story from a time when some major news outlets conducted investigative journalism.
There is concern that getting one of these vaccinations may sensitize vaccine
recipients to more severe disease than if they were not vaccinated.
According to authors of a new article in , the risk of harm from taking a COVID‐19 vaccine is well hidden in clinical trial protocols and consent forms for ongoing COVID-19 vaccine trials.
The authors state, in order to meet the medical ethics standard of patient comprehension for informed consent the specific and significant COVID‐19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval.
The technical term ADE, stands for antibody-dependent enhancement. This can strengthen viral entry into host cells and worsen disease.
An article in Science magazine, titled, Public needs to prep for vaccine side effects, states “people may need a hotline with a nurse triaging, for people who have serious reactions, figuring out if you need to go to the hospital or not. Will their medical expenses be covered if they do? These are important questions.”
One vaccine trial participant is alleging serious side-effects. The participant, who is around 40 years old, has filed a lawsuit. According to his legal claim, he has been diagnosed with “acute neuro encephalopathy”, which has allegedly been linked as a side-effect of the Covishield shots that he took on 1 October. The vaccine he received named Covishield, is being developed by the University of Oxford and drugmaker AstraZeneca.
In closing, is it even ethical to genetically alter humans? What would be the long term effects? There has been more thought given to the implications of genetically engineering beets than altering the DNA given to us by our ancestors. Who knows what is best for your body and the bodies of your children?